PERTUZUMAB
pertuzumab 420 mg/14 mL injection, 14 mL vial
PERTUZUMAB (10308M)
10308M
Manner of administration:Injection
Restriction
Indication: Metastatic (Stage IV) HER2 positive breast cancer
Treatment phase: Continuing treatment
Quantities & Cost
| Max amount | # of repeats | DPMA | Max safety net | General Patient Charge |
|---|---|---|---|---|
| Max amount: 420 mg | # of repeats: 3 | DPMA: $2,948.53 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | ||||
| Perjeta
(pertuzumab 420 mg/14 mL injection, 14 mL vial)
|
||||
